Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17

Summary

This study is a companion protocol that will use the data generated by Conatus' study of emricasan under protocol IDN-6556-17.The IDN-6556-17 study is a Phase 2, multicenter, double-blind, placebo-controlled trial of Emricasan in subjects with decompensated non-alcoholic steatohepatitis (NASH) cirrhosis.

Timeline

Start

2017-06-28

Primary completion

2019-07-15

Completion

2019-07-15

Outcome

Outcome not reported

Stopped: “Sponsor of Trial decision”

Drugs

Indications